Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Translation of bi-directional transcripts enhances MHC-I peptide diversity
RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris Cité, Hôpital St. Louis, Paris, France.
UMR 1015 Immunologie des tumeurs et immunothérapie contre le cancer, Université Paris Sud, B2M, Gustave Roussy, Villejuif, France.
Visa övriga samt affilieringar
2025 (Engelska)Ingår i: Frontiers in Immunology, E-ISSN 1664-3224, Vol. 16, artikel-id 1554561Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Antisense transcripts play an important role in generating regulatory non-coding RNAs but whether these transcripts are also translated to generate functional peptides remains poorly understood. In this study, RNA sequencing and six-frame database generation were combined with mass spectrometry analysis of peptides isolated from polysomes to identify Nascent Pioneer Translation Products (Na-PTPs) originating from alternative reading frames of bi-directional transcripts. Two Na-PTP originating peptides derived from antisense strands stimulated CD8+ T cell proliferation when presented to peripheral blood mononuclear cells (PBMCs) from nine healthy donors. Importantly, an antigenic peptide derived from the reverse strand of two cDNA constructs was presented on MHC-I molecules and induced CD8+ T cell activation. The results demonstrate that three-frame translation of bi-directional transcripts generates antigenic peptide substrates for the immune system. This discovery holds significance for understanding the origin of self-discriminating peptide substrates for the major histocompatibility class I (MHC-I) pathway and for enhancing immune-based therapies against infected or transformed cells.

Ort, förlag, år, upplaga, sidor
Frontiers Media S.A., 2025. Vol. 16, artikel-id 1554561
Nyckelord [en]
bi-directional transcripts, bi-directional translation, MHC-I epitope, Pioneer Translation Products, reverse strand antigenic peptides
Nationell ämneskategori
Immunologi inom det medicinska området Immunologi
Identifikatorer
URN: urn:nbn:se:umu:diva-237344DOI: 10.3389/fimmu.2025.1554561ISI: 001455088300001PubMedID: 40165968Scopus ID: 2-s2.0-105001448358OAI: oai:DiVA.org:umu-237344DiVA, id: diva2:1954063
Tillgänglig från: 2025-04-23 Skapad: 2025-04-23 Senast uppdaterad: 2025-04-23Bibliografiskt granskad

Open Access i DiVA

fulltext(2523 kB)52 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2523 kBChecksumma SHA-512
d92666c1edfa8ba39639cd7c85c8c0a061c505e574d79b44884c5f51271da4510b714b4fcec6a72729467767f9c0110f4fe640cc9bdd95fc42a60f2d40389c16
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Wang, LixiaoGnanasundram, Sivakumar VadivelFåhraeus, Robin

Sök vidare i DiVA

Av författaren/redaktören
Wang, LixiaoGnanasundram, Sivakumar VadivelFåhraeus, Robin
Av organisationen
Institutionen för medicinsk biovetenskap
I samma tidskrift
Frontiers in Immunology
Immunologi inom det medicinska områdetImmunologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 53 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 456 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf